Skip to main content

Advertisement

SpringerLink
Log in

Cytoreductive Surgery and Intraperitoneal Chemohyperthermia for Recurrent Peritoneal Carcinomatosis from Ovarian Cancer

  • Original Scientific Reports
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Aggressive surgical cytoreduction has been shown to have a positive impact on survival of patients with ovarian cancer. After first-line chemotherapy, 47% of patients relapse within 5 years, and median survival after second line chemotherapy is 10—15 months. Adding intraperitoneal chemohyperthermia (IPCH) to surgical cytoreduction could further control ceolomic spread of disease. The aim of this study was to determine morbidity and mortality, regional relapse-free survival and, preliminarily, overall survival after combining cytoreductive surgery with IPCH for the treatment of peritoneal carcinomatosis from ovarian epithelial cancer relapsed after prior chemotherapy. Thirty women affected with such a relapse were included. Patients underwent extensive cytoreductive surgery including tumor resections and peritonectomy, followed by intraoperative IPCH with cisplatin. Complete surgical cytoreduction down to nodules less than 2.5 mm (CC0—CC1) was obtained in 23 patients (77%). One patient died postoperatively from a pulmonary embolism. Major postoperative morbidity was 5/30 (16.7%). We registered one case of anastomotic leakage, a spontaneous ileum perforation, a postoperative cholecystitis, a hydrothorax, and one patient with bone marrow toxicity. Kaplan-Meier estimates of median locoregional relapse-free survival and median overall survival were 17.1 months and 28.1 months, respectively. Patients with CC0—CC1 had locoregional relapse-free and overall survival rates of 24.4 and 37.8 months, whereas the remainder had survival rates of 4.1 and 11.0 months. We concluded that cytoreductive surgery combined with IPCH is feasible with acceptable morbidity and mortality and seems to promise good results in selected patients affected with peritoneal carcinomatosis from ovarian cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  1. WP McGuire WJ Hoskins MF Brady et al. (1996) ArticleTitleCyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer N. Engl. J. Med. 334 1–6

    Google Scholar 

  2. MJ Piccart K Bertelsen K James et al. (2000) ArticleTitleRandomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results J. Natl. Cancer Inst. 92 669–708

    Google Scholar 

  3. M Markman (2003) ArticleTitleIntraperitoneal antineoplastic drug delivery: rationale and results Lancet Oncol. 4 277–283 Occurrence Handle10.1016/S1470-2045(03)01074-X Occurrence Handle1:CAS:528:DC%2BD3sXjsVart7Y%3D Occurrence Handle12732164

    Article  CAS  PubMed  Google Scholar 

  4. DS Alberts PY Liu EV Hannigan et al. (1996) ArticleTitleIntraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer N. Engl. J. Med. 335 1950–1955

    Google Scholar 

  5. M Markman BN Bundy DS Alberts et al. (2001) ArticleTitlePhase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group J. Clin. Oncol. 19 1001–1007 Occurrence Handle1:CAS:528:DC%2BD3MXhvFersbg%3D Occurrence Handle11181662

    CAS  PubMed  Google Scholar 

  6. Armstrong DK, Bundy BN, Baergen R, et al. Randomized phase III study of intravenous (IV) paclitaxel and cisplatin versus IV paclitaxel, intraperitoneal (IP) cisplatin and IP paclitaxel in optimal stage III epithelial ovarian cancer (OC): a Gynecologic Oncologic Group trial (GOG 172). Proc. Am. Soc. Clin. Oncol. 2002;21:201a, 202 (abstr 803)

  7. JS Spratt JA Adcocj M Muskovin et al. (1980) ArticleTitleClinical delivery system for peritoneal hyperthermic chemotherapy Cancer Res. 40 256–260 Occurrence Handle1:STN:280:Bi%2BD1cbnvV0%3D Occurrence Handle6766084

    CAS  PubMed  Google Scholar 

  8. BC Giovanella JS Stehlin AC Morgan (1976) ArticleTitleSelective lethal effect of supranormal temperatures on human neoplastic cells Cancer Res. 11 3944–3950

    Google Scholar 

  9. L Benoit C Duvillard P Rat et al. (1999) ArticleTitle[The effect of intra-abdominal temperature on the tissue and tumor diffusion of intraperitoneal cisplatin in a model of peritoneal carcinomatosis in rats.] Effets de la temperature intra-abdominale sur la diffusion tissulaire et tumorale du cisplatine intraperitoneal dans un modele de carcinose peritoneale chez le rat Chirurgie 124 375–379 Occurrence Handle1:STN:280:DC%2BD3c%2FhtlOisQ%3D%3D Occurrence Handle10546390

    CAS  PubMed  Google Scholar 

  10. EL Zakris MW Dewhirst JE Riviere et al. (1987) ArticleTitlePharmacokinetics and toxicity of intraperitoneal cisplatin combined with regional hyperthermia J. Clin. Oncol. 5 1613–1620 Occurrence Handle1:STN:280:BieD3M%2Fht1U%3D Occurrence Handle3655858

    CAS  PubMed  Google Scholar 

  11. T Fujimura Y Honemura H Fujita et al. (1999) ArticleTitleChemohyperthermic peritoneal perfusion for peritoneal dissemination in various intra-abdominal malignancies Int J Surg 84 60–66 Occurrence Handle1:STN:280:DyaK1Mzksleksg%3D%3D

    CAS  Google Scholar 

  12. FN Gilly AC Beaujard O Glehen et al. (1999) ArticleTitlePeritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: a phase I-II study Anticancer Res. 19 2317–2321 Occurrence Handle1:STN:280:DyaK1MvgtFGksw%3D%3D Occurrence Handle10472351

    CAS  PubMed  Google Scholar 

  13. C Zanon R Clara M Bortolini et al. (2001) ArticleTitleChemohyperthermia for advanced abdominal malignancies: a new procedure with closed abdomen and previously performed anastomosis Int. J. Hyperthermia 17 456–464 Occurrence Handle10.1080/02656730110068311 Occurrence Handle1:STN:280:DC%2BD3MrktVyhsQ%3D%3D Occurrence Handle11587082

    Article  CAS  PubMed  Google Scholar 

  14. PH Sugarbaker (2000) Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal surface malignancies M Markman (Eds) Regional Chemotherapy Humana Press Totowa, NJ 151–166

    Google Scholar 

  15. P Sugarbaker (1995) ArticleTitlePeritonectomy procedures Ann. Surg. 221 29–42 Occurrence Handle1:STN:280:ByqC38nnt1c%3D Occurrence Handle7826158

    CAS  PubMed  Google Scholar 

  16. P Jacquet PH Sugarbaker (1996) ArticleTitleCurrent methodologies for clinical assessment of patients with peritoneal carcinomatosis J. Exp. Clin. Cancer Res. 15 49–58

    Google Scholar 

  17. D Elias S Antun A Goharin et al. (2000) ArticleTitleResearch on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection Int. J. Surg. Investig. 1 431–439 Occurrence Handle1:STN:280:DC%2BD3Mzgt1SrsA%3D%3D Occurrence Handle11341599

    CAS  PubMed  Google Scholar 

  18. ME Burg Particlevan der M Lent Particlevan M Buyse et al. (1995) ArticleTitleThe effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer N. Engl. J. Med. 332 629–634

    Google Scholar 

  19. F Cavaliere P Perri F Filippo ParticleDi et al. (2000) ArticleTitleTreatment of peritoneal carcinomatosis with intent to cure J. Surg. Oncol. 74 41–44 Occurrence Handle10.1002/1096-9098(200005)74:1<41::AID-JSO10>3.0.CO;2-R Occurrence Handle1:STN:280:DC%2BD3czitFCktw%3D%3D Occurrence Handle10861608

    Article  CAS  PubMed  Google Scholar 

  20. RR Barakat P Sabbatici D Bhaskaran et al. (2002) ArticleTitleIntraperitoneal chemotherapy for ovarian carcinoma: results of long term follow-up J. Clin. Oncol. 20 694–698 Occurrence Handle10.1200/JCO.20.3.694 Occurrence Handle11821450

    Article  PubMed  Google Scholar 

  21. RC Rietbroek PJM Vaart Particlevan de J Haveman et al. (1997) ArticleTitleHyperthermia enhances the citotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells Cancer Res Clin Oncol 123 6–12 Occurrence Handle1:CAS:528:DyaK2sXhtFSksbs%3D

    CAS  Google Scholar 

  22. P Pontiggia S Barni G Mathè et al. (1995) ArticleTitleLysosomal exocytosis induced by hyperthermia : a new model of cancer cell death. II. Effect on peritoneal macrophages Biomed. Pharmacother. 49 429–430 Occurrence Handle10.1016/0753-3322(96)82680-1 Occurrence Handle1:STN:280:BymA3cnmvVA%3D Occurrence Handle8746079

    Article  CAS  PubMed  Google Scholar 

  23. G Panteix A Beaujard F Garbit et al. (2002) ArticleTitlePopulation pharmacokinetics of cisplatin in patients with advanced ovarian cancer during intraperitoneal hyperthermia chemotherapy Anticancer Res. 22 1329–1336 Occurrence Handle1:CAS:528:DC%2BD38XmsFWrt7Y%3D Occurrence Handle12168946

    CAS  PubMed  Google Scholar 

  24. MA Steller MJ Egorin EL Trimble et al. (1999) ArticleTitleA pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer Cancer Chemother. Pharmacol. 43 106–114 Occurrence Handle10.1007/s002800050870 Occurrence Handle1:CAS:528:DyaK1MXhvFWkur4%3D Occurrence Handle9923815

    Article  CAS  PubMed  Google Scholar 

  25. E Bree ParticleDe H Rosing JH Beijnen et al. (2003) ArticleTitlePharmacokinetic study of docetaxel in intraoperative hyperthermic i.p. chemotherapy for ovarian cancer Anticancer Drugs 14 103–110 Occurrence Handle10.1097/00001813-200302000-00003 Occurrence Handle12569296

    Article  PubMed  Google Scholar 

  26. N Vange Particlevan der AR Goethem ParticleVan FA Zoetemulder et al. (2000) ArticleTitleExtensive cytoreductive surgery combined with intra-operative intraperitoneal perfusion with cisplatin under hyperthermic conditions (OVHIPEC) in patients with recurrent ovarian cancer: a feasibility pilot Eur. J. Surg. Oncol. 26 663–668 Occurrence Handle10.1053/ejso.2000.0978 Occurrence Handle11078613

    Article  PubMed  Google Scholar 

  27. PJ Vaart Particleder N Vange Particlevan der FA Zoetmulder et al. (1998) ArticleTitleIntraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines Eur. J. Cancer 34 148–154 Occurrence Handle10.1016/S0959-8049(97)00370-5 Occurrence Handle9624250

    Article  PubMed  Google Scholar 

  28. W ten Bokkel Huinink M Gore J Carmichael et al. (1997) ArticleTitleTopotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer J. Clin. Oncol. 15 2183–2193 Occurrence Handle1:CAS:528:DyaK2sXlsFKqtrg%3D Occurrence Handle9196130

    CAS  PubMed  Google Scholar 

  29. FM Muggia JD Hainsworth S Jetters et al. (1997) ArticleTitlePhase II study of liposomal doxorubicin in refractory ovarian cancer: Antittumor activity and toxicity modification by liposomal encapsulation J. Clin. Oncol. 15 987–993 Occurrence Handle1:CAS:528:DyaK2sXitFCgs7k%3D Occurrence Handle9060537

    CAS  PubMed  Google Scholar 

  30. AN Gordon JT Fleagle D Guthrie et al. (2001) ArticleTitleRecurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan J. Clin. Oncol. 19 3312–3322 Occurrence Handle1:CAS:528:DC%2BD3MXlvVamsr8%3D Occurrence Handle11454878

    CAS  PubMed  Google Scholar 

  31. M Deraco CR Rossi E Pennacchioli et al. (2001) ArticleTitleCytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical study Tumori 87 120–126 Occurrence Handle1:STN:280:DC%2BD3MvlvVCrsA%3D%3D Occurrence Handle11504363

    CAS  PubMed  Google Scholar 

  32. O Glehen F Mithieux D Osinsky et al. (2003) ArticleTitleSurgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: a phase II study J. Clin. Oncol. 21 799–806 Occurrence Handle10.1200/JCO.2003.06.139 Occurrence Handle1:STN:280:DC%2BD3s%2Fpsleiuw%3D%3D Occurrence Handle12610177

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, S. Giovanni Battista Antica Sede Hospital, Via Cavour 31, 10100, Torino, Italy

    Claudio Zanon M.D., Renzo Clara M.D., Massimiliano Bortolini M.D., Silvia Cornaglia M.D., Paolo Simone M.D., Francesco Bruno M.D., Leonarda De Riu, Mario Airoldi M.D. & Fulvia Pedani M.D.

  2. Department of Oncology, San Giovanni Battista Hospital, Corso Bramante 88, 10100, Torino, Italy

    Isabella Chiappino M.D.

Authors
  1. Claudio Zanon M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Renzo Clara M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Isabella Chiappino M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Massimiliano Bortolini M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Silvia Cornaglia M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Paolo Simone M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Francesco Bruno M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Leonarda De Riu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mario Airoldi M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Fulvia Pedani M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claudio Zanon M.D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zanon, C., Clara, R., Chiappino, I. et al. Cytoreductive Surgery and Intraperitoneal Chemohyperthermia for Recurrent Peritoneal Carcinomatosis from Ovarian Cancer. World J. Surg. 28, 1040–1045 (2004). https://doi.org/10.1007/s00268-004-7461-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-004-7461-x

Keywords

Search

Navigation